Nephrology Perspective

• May 10 2024 This Week in Cardiology   Inclisiran, sodium-channel blocker safety, analytic flexibility, the work-up of patients with HF, and BP in older patients are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, May 10, 2024
• C3 Glomerulopathy Diagnosis Dr Arnold B. Alper, Jr, discusses challenges in C3 glomerulopathy (C3G) diagnosis.
  Medscape Nephrology, May 09, 2024
• Should AI Join Ethics Committees? Ethicist Says Not Yet   Ethicist Art Caplan discusses the potential future role of AI on medical ethics committees.
  Medscape Business of Medicine, May 08, 2024
• It Would Be Nice if Olive Oil Really Did Prevent Dementia   Alas, nutritional epidemiology studies! Dr F. Perry Wilson shares his level of trust in new data about olive oil consumption and dementia-related death.
  Medscape, May 07, 2024
• May 03 2024 This Week in Cardiology   The DEDICATE trial of TAVR vs SAVR, more on renal denervation, inclisiran, and marketing disguised as science are the topics John Mandrola, MD, discusses in today’s podcast.
  theheart.org on Medscape, May 03, 2024
• Intermittent Fasting + HIIT: Fitness Fad or Fix?   The combination of two challenging lifestyle choices appears to be more effective than either alone, according to a new study.
  Medscape, May 01, 2024
• Ethics of Living Limb Donation: Is Donor Competent?   Ethicist Art Caplan discusses considerations for living limb donation.
  Medscape Business of Medicine, May 01, 2024
• Hereditary Amyloidosis: 5 Things to Know The heterogeneity of hereditary amyloidosis can delay diagnosis and seriously affect prognosis and patient quality of life; these five things are need-to-know.
  Medscape Oncology, April 29, 2024
• We've Come Full Circle in Managing CKM A recent statement provides guidance on managing cardiovascular-kidney-metabolic syndrome, bringing us back to the roots of treating metabolic syndrome, writes Naresh Kanumilli, MBBS.
  Medscape Diabetes & Endocrinology, April 24, 2024
• Opportunistic AI for Medical Scans A remarkable wealth of data are being missed.
  Medscape, April 23, 2024
• Conscience Laws: Inform Patients Early of All Options   Ethicist Art Caplan discusses the rise of state conscience laws and doctors' obligation to inform patients of all options for receiving care.
  Medscape Business of Medicine, April 23, 2024
• Are Women Better Doctors Than Men?   Investigators took a unique approach to try to answer this age-old question in medicine.
  Medscape, April 22, 2024
• Deciding When to Use Immunosuppression for IgA Nephropathy   Dr Andrew Bomback of Columbia University discusses the most common question he gets about treating IgA nephropathy: when to treat with immunosuppressants.
  Medscape Nephrology, April 18, 2024
• Infographic: Doctors' Pay and If They Think It's Enough Physicians reveal their compensation rose about 3% on average in 2023 and discuss whether the profession in general and they individually are adequately paid.
  Medscape, April 18, 2024
• S2 Episode 5: Pulmonary Hypertension: Essential Insights for Cardiologists   Drs Michelle Kittleson and Ronald Oudiz dive into everything cardiologists need to know about the diagnosis and treatment of pulmonary hypertension.
  Medscape, April 18, 2024
• 'Difficult Patient': Stigmatizing Words and Medical Error   In a hospital study, the use of certain words and language patterns in the medical record was linked with diagnostic errors. Dr F Perry Wilson comments.
  Medscape, April 15, 2024
• A Shot in the Arm for Uncontrolled Hypertension   Cardiologists Michelle O'Donoghue and Akshay Desai discuss the results of KARDIA-2 on the siRNA drug zilebesiran in patients with uncontrolled hypertension and the potential role of renal denervation.
  theheart.org on Medscape, April 15, 2024
• Apr 12 2024 This Week in Cardiology   ACC Recap #1: DanGer Shock (plus a sobering JAMA research letter on Impella use), REDUCE-AMI, PREVENT, and EMPACT-MI are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, April 12, 2024
• EMPACT-MI: Another SGLT2 Inhibitor Miss Post-MI Empagliflozin added to standard care did not improve outcomes in post-MI patients at risk for heart failure. John Mandrola, MD, sees the diminishing returns for add-on drugs as positive for patients.
  theheart.org on Medscape, April 12, 2024
• Managing CKD in Primary Care: Latest Guidelines   An explosion of new treatments can stave off the need for dialysis in many patients with CKD.
  Medscape Family Medicine, April 10, 2024
• Complement 3 Glomerulopathy: 5 Things to Know Complement 3 glomerulopathy is a very rare kidney disease requiring biopsy and specialized tests for diagnosis. These five things to know are crucial to understanding C3G.
  Medscape Nephrology, April 05, 2024
• Q&A: Immunosuppressive Therapy in IgA Nephropathy Dr Arnold B. Alper, Jr, reviews the role of immunosuppressive therapies in the treatment of IgA nephropathy.
  Medscape Nephrology, April 05, 2024
• Diagnose Left Flank Pain in a 61-Year-Old Man Are you familiar with the presentation, differential diagnosis, and workup for renal cell carcinoma? Dr Karl J. D'Silva provides a brief guide.
  Medscape Oncology, April 02, 2024
• How to Keep Your Patients Safe This Ramadan With increasing prevalence of chronic illnesses, old age, and frailty, doctors are likely to encounter Muslim patients with chronic conditions asking for their advice.
  Medscape UK, February 27, 2024